KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Nektar Therapeutics (NKTR) Shares Outstanding: 2010-2022

Historic Shares Outstanding for Nektar Therapeutics (NKTR) over the last 4 years, with Jun 2022 value amounting to $187.4 million.

  • Nektar Therapeutics' Shares Outstanding rose 1.98% to $187.4 million in Q2 2022 from the same period last year, while for Jun 2022 it was $187.4 million, marking a year-over-year increase of 1.98%. This contributed to the annual value of $185.5 million for FY2021, which is 2.99% up from last year.
  • As of Q2 2022, Nektar Therapeutics' Shares Outstanding stood at $187.4 million, which was up 0.61% from $186.3 million recorded in Q1 2022.
  • Over the past 5 years, Nektar Therapeutics' Shares Outstanding peaked at $187.4 million during Q2 2022, and registered a low of $162.4 million during Q1 2018.
  • For the 3-year period, Nektar Therapeutics' Shares Outstanding averaged around $182.6 million, with its median value being $183.0 million (2021).
  • Data for Nektar Therapeutics' Shares Outstanding shows a peak YoY climbed of 8.78% (in 2018) over the last 5 years.
  • Over the past 5 years, Nektar Therapeutics' Shares Outstanding (Quarterly) stood at $173.5 million in 2018, then climbed by 1.71% to $176.5 million in 2019, then rose by 2.03% to $180.1 million in 2020, then grew by 2.99% to $185.5 million in 2021, then increased by 1.98% to $187.4 million in 2022.
  • Its Shares Outstanding stands at $187.4 million for Q2 2022, versus $186.3 million for Q1 2022 and $185.5 million for Q4 2021.